BGI’s DNA Methylation Detection Kit Gets Thailand’s TFDA Medical Device Import License

BGI’s DNA Methylation Detection Kit for Human SDC2, ADHFE1 and PPP2R5C Genes (Real-time PCR) obtains the Medical Device Import License of Thailand Food and Drug Administration.

The detection kit is an auxiliary diagnosis method recommended by clinicians. It can provide patients with an option in colorectal cancer (CRC) screening besides colonoscopy. According to PubMed.gov, 2020, CRC ranks the third most common cancer and accounts for 11 percent of cancer cases in Thailand, with more than 10,000 new cases occurring annually. Effective detection is the crucial step of CRC prevention and subsequent treatment.

The detection kit will bring significant implications for CRC prevention in Thailand and reduce the occurrence of related diseases.